Stock HCIL HONGCHANG INTERNATIONAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Hongchang International Co., Ltd

Equities

HCIL

US42831T2024

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 14:31:03 06/05/2024 BST 		5-day change 1st Jan Change
0.2501 USD +12.35% Intraday chart for Hongchang International Co., Ltd +12.35% -28.30%
04-01 Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-01 Hongchang International Co., Ltd Announces Board Changes CI

Business Summary

Hongchang International Co Ltd, formerly Heyu Biological Technology Corp, is a holding company mainly engaged in research and development and manufacture a medical product, the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber (the Chamber). Utilizing submillimeter waves, the Chamber is a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber.

Managers

Managers TitleAgeSince
Zeng Qiang Lin CEO
 Chief Executive Officer 28 16/02/23
Siong Ang Ban CHM
 Chairman 49 17/04/18

Members of the board

Members of the board TitleAgeSince
Siong Ang Ban CHM
 Chairman 49 17/04/18
Zeng Qiang Lin CEO
 Chief Executive Officer 28 16/02/23
Zhen Zhu Lin BRD
 Director/Board Member 32 20/08/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 518,831,367 12,295,756 ( 2.370 %) 0 2.370 %

Shareholders

NameEquities%Valuation
Zeng Qiang Lin
68.10 %
353,322,843 68.10 % 230 M $
Zhen Zhu Lin
12.00 %
62,259,532 12.00 % 40 M $
Ban Siong Ang
10.80 %
56,011,747 10.80 % 36 M $
Pheng Ang Hooi
6.735 %
34,941,489 6.735 % 23 M $

Company contact information

Hongchang International Co., Ltd.

Block 20, Yuanhong Investment Zone Donggao Village

350300, Fuzhou

+

address Hongchang International Co., Ltd(HCIL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
HONGCHANG INTERNATIONAL CO., LTD Stock Hongchang International Co., Ltd
-28.30% 130M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 698B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.40% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 328B
ABBVIE INC. Stock AbbVie Inc.
+3.50% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.34% 238B
NOVARTIS AG Stock Novartis AG
+6.68% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+8.62% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. HCIL Stock
  4. Company Hongchang International Co., Ltd